10,035 Shares in Cigna Group $CI Acquired by MASTERINVEST Kapitalanlage GmbH

MASTERINVEST Kapitalanlage GmbH purchased a new stake in shares of Cigna Group (NYSE:CI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,035 shares of the health services provider’s stock, valued at approximately $3,317,000.

Other large investors also recently made changes to their positions in the company. Flaharty Asset Management LLC acquired a new position in shares of Cigna Group during the 1st quarter valued at $28,000. 1248 Management LLC purchased a new position in Cigna Group in the first quarter valued at about $29,000. Solstein Capital LLC acquired a new position in shares of Cigna Group during the second quarter worth about $29,000. Chilton Capital Management LLC purchased a new stake in shares of Cigna Group in the second quarter worth about $30,000. Finally, Activest Wealth Management boosted its position in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 0.9%

Shares of NYSE:CI opened at $274.70 on Friday. The firm has a market cap of $73.38 billion, a PE ratio of 12.12, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The company has a fifty day simple moving average of $280.44 and a 200 day simple moving average of $294.02. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the business earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Insider Activity

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

CI has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reduced their price target on Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Robert W. Baird reduced their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Cantor Fitzgerald dropped their price target on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Finally, Wells Fargo & Company cut their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $331.77.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.